BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21175915)

  • 21. Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids.
    Smit DL; de Hon O; Venhuis BJ; den Heijer M; de Ronde W
    Scand J Med Sci Sports; 2020 Mar; 30(3):531-539. PubMed ID: 31663164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The medical aspect of using anabolic androgenic steroids in males attending gyms of Saint-Petersburg].
    Lykhonosov MP; Babenko AY
    Probl Endokrinol (Mosk); 2019 May; 65(1):19-30. PubMed ID: 31091047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anabolic agents.
    Sturmi JE; Diorio DJ
    Clin Sports Med; 1998 Apr; 17(2):261-82. PubMed ID: 9580841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse.
    Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS
    Eur Psychiatry; 2006 Dec; 21(8):551-62. PubMed ID: 16356691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Growth hormone and IGF-1 as doping agents in competitive sport].
    Jóźków P; Medraś M
    Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can anabolic steroids or human growth hormone affect the growth and maturation of adolescent athletes?
    Rogol AD
    Pediatr Exerc Sci; 2014 Nov; 26(4):423-7. PubMed ID: 25372376
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of hormones in doping and cancer risk.
    De Santi M; Baldelli G; Brandi G; ;
    Ann Ig; 2019; 31(6):590-594. PubMed ID: 31616903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters.
    Jørstad ML; Scarth M; Torgersen S; Pope HG; Bjørnebekk A
    Brain Behav; 2023 Jul; 13(7):e3040. PubMed ID: 37150843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
    Santos AM; da Rocha MS; da Silva MF
    Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abuse of supraphysiologic doses of anabolic steroids.
    Hall RC; Hall RC
    South Med J; 2005 May; 98(5):550-5. PubMed ID: 15954512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone.
    Grönbladh A; Nylander E; Hallberg M
    Brain Res Bull; 2016 Sep; 126(Pt 1):127-137. PubMed ID: 27156843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.
    Onakomaiya MM; Henderson LP
    Psychopharmacology (Berl); 2016 Feb; 233(4):549-69. PubMed ID: 26758282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization.
    Perry PJ; Lund BC; Deninger MJ; Kutscher EC; Schneider J
    Clin J Sport Med; 2005 Sep; 15(5):326-30. PubMed ID: 16162991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?
    Kanayama G; Cohane GH; Weiss RD; Pope HG
    J Clin Psychiatry; 2003 Feb; 64(2):156-60. PubMed ID: 12633124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
    Tentori L; Graziani G
    Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.
    Nieschlag E; Vorona E
    Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.
    Kanayama G; Hudson JI; Pope HG
    Drug Alcohol Depend; 2009 Jun; 102(1-3):130-7. PubMed ID: 19339124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out].
    de Ronde W
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1820-4. PubMed ID: 18783159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anabolic-androgenic steroids and adolescents: recent developments.
    Denham BE
    J Addict Nurs; 2012 Oct; 23(3):167-71, quuiz 172-3. PubMed ID: 24335733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.